AIM IMMUNOTECH INC. Other Noncash Income (Expense)
AIM IMMUNOTECH INC. (AIM) reported Other Noncash Income (Expense) of -$68.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2026-05-15
- AIM IMMUNOTECH INC. other noncash income (expense) for the quarter ending 2026-03-31 was -$68.00K.
- AIM IMMUNOTECH INC. other noncash income (expense) for the quarter ending 2025-12-31 was -$154.00K.
- AIM IMMUNOTECH INC. other noncash income (expense) for the quarter ending 2025-09-30 was -$59.00K.
- AIM IMMUNOTECH INC. other noncash income (expense) for the quarter ending 2025-06-30 was -$17.00K.
- AIM IMMUNOTECH INC. other noncash income (expense) for fiscal 2025 was -$294.00K.
- AIM IMMUNOTECH INC. other noncash income (expense) for fiscal 2024 was -$304.00K.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 6 month | Other Noncash Income (Expense) 9 month | Other Noncash Income (Expense) 12 month |
|---|---|---|---|---|
| 2026-03-31 | -$68.00K 10-Q · filed 2026-05-15 | -$222.00K derived: sum of 2 quarters · filed 2026-05-15 | -$281.00K derived: sum of 3 quarters · filed 2026-05-15 | -$298.00K derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-12-31 | -$154.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | -$213.00K derived: sum of 2 quarters · filed 2026-03-27 | -$230.00K derived: sum of 3 quarters · filed 2026-03-27 | -$294.00K 10-K · filed 2026-03-27 |
| 2025-09-30 | -$59.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-17 | -$76.00K derived: sum of 2 quarters · filed 2025-11-17 | -$140.00K 10-Q · filed 2025-11-17 | -$218.00K derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-06-30 | -$17.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$81.00K 10-Q · filed 2025-08-14 | -$159.00K derived: sum of 3 quarters · filed 2026-05-15 | -$235.00K derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-03-31 | -$64.00K 10-Q · filed 2026-05-15 | -$142.00K derived: sum of 2 quarters · filed 2026-05-15 | -$218.00K derived: sum of 3 quarters · filed 2026-05-15 | -$435.00K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | -$78.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | -$154.00K derived: sum of 2 quarters · filed 2026-03-27 | -$371.00K derived: sum of 3 quarters · filed 2026-03-27 | -$304.00K 10-K · filed 2026-03-27 |
| 2024-09-30 | -$76.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-17 | -$293.00K derived: sum of 2 quarters · filed 2025-11-17 | -$226.00K 10-Q · filed 2025-11-17 | |
| 2024-06-30 | -$217.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$150.00K 10-Q · filed 2025-08-14 | ||
| 2024-03-31 | $67.00K 10-Q · filed 2025-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |